Product Information
GABAPENTIN ER 300 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $1.0468 per EA under NDC 31722009190. Its NADAC has been published 102 times since Jul 17, 2024.
The High Outlier badge above means this manufacturer's average price in the GABAPENTIN market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722009190
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA218075On Market Since
2/26/2024
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN ER 300 MG TABLET has been published 102 times since Jul 17, 2024, and over the history we have for it it has declined 36.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0468 per EA |
|---|---|
| All-time high | $2.2901 (Jun 11, 2025) |
| All-time low | $1.0468 (Jun 17, 2026) |
| 52-week high | $2.2548 |
| 52-week low | $1.0468 |
| Median price | $1.5967 |
| Average price | $1.7310 |
| Largest weekly change | +35.5% (Aug 21, 2024) |
| Weeks tracked | 102 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN ER 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN ER 300 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $1.0468 per EA (NDC 31722009190), effective Jun 24, 2026.
How has the price of GABAPENTIN ER 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for GABAPENTIN ER 300 MG TABLET has declined 36.3%. It has been tracked across 102 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for GABAPENTIN ER 300 MG TABLET?
Since Jul 17, 2024, the NADAC for GABAPENTIN ER 300 MG TABLET has ranged from a low of $1.0468 (Jun 17, 2026) to a high of $2.2901 (Jun 11, 2025), with a median of $1.5967 per EA.
Are there cheaper alternatives to GABAPENTIN ER 300 MG TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GABAPENTIN 300 MG CAPSULE, is $0.0324 per EA — about 97% below GABAPENTIN ER 300 MG TABLET.
Who manufactures GABAPENTIN ER 300 MG TABLET?
GABAPENTIN ER 300 MG TABLET (NDC 31722009190) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification